Nanovis Logo

 

NANOVIS® Corporate News

Nanovis $5.5 million investment round

Nanovis announces successful completion of $5.5 million investment round to fund technology-driven growth

This funding supports surging demand from surgeons and distributors for Nanovis’ nano-technology enhanced spinal implants.

Carmel, Ind. (Aug. 21, 2018) Nanovis, an innovative and fast-growing technology company selling nano-technology enhanced spinal implants, announced today the successful completion of a $5.5 million funding round brokered by Commenda Securities. Key investors include Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures.

FDA Clearance of FortiCore®
FDA Clearance of FortiCore®

Nanovis Announces FDA Clearance of FortiCore® PLIF and TLIF Spinal Interbodies with Nanosurface Features

Spinal Implants Cleared with the Most Advanced Nanosurface and Best Imaging

Carmel, Ind. (March 28, 2018) Nanovis, today announced the successful FDA clearance of its FortiCore® TLIF and PLIF interbodies featuring a Nanosurface-enhanced deeply porous titanium scaffold intermolded with a PEEK core.

Successful Alpha Launch of the FortiCore

Nanovis announces a Successful Alpha Launch of the FortiCore® PLIF and the 2,000th FortiCore® Interbody Implantation.

Nanovis’ Deeply Porous Spinal Implants Show Favorable Clinical Adoption.

Carmel and Columbia City, Ind. (February 16, 2017) – Nanovis, a life sciences company committed to developing implant systems that reduce fixation related complications and infections, today announced the successful alpha launch of its FortiCore® PLIF featuring a deeply porous titanium scaffold interdigitated with a PEEK core, and implantation of the 2,000th FortiCore® implant.

National Institutes of Health Awards Second Research Grant to Nanovis

National Institutes of Health Awards Second Research Grant to Nanovis

Nanovis’ Deeply Porous Spinal Implants with Nanotube-Enhanced Surfaces May Significantly Improve Patient Recovery from Spinal Fusion Procedures

Carmel, Ind. (March 8, 2016) – Nanovis, a life sciences company committed to developing scientifically advanced regenerative platforms for implantable medical devices, today announced a grant award from the National Institute on Aging, part of the National Institutes of Health (NIH).

Nanovis Launches Expanded FortiCore

Nanovis Launches Expanded FortiCore® Line of Interbody Fusion Devices at NASS

Proprietary Approach Layers Titanium Scaffold Surface Technology on PEEK Implants Creating Differentiated Devices

CARMEL, Ind.Oct. 15, 2015 /PRNewswire/ — Nanovis, a life sciences company committed to developing scientifically advanced regenerative platforms for implantable medical devices, today announced the availability of the FortiCore® wedge shaped lordotic cervical cage and a transforaminal lumbar interbody fusion (TLIF) device with increased scaffolding.

Research Grant to Nanovis Spine

National Institutes of Health Awards Research Grant to Nanovis Spine to Further Explore Benefits of Nanotube Enhanced FortiCore® Spinal Implant Technology

Combination of a deeply porous titanium scaffold with a PEEK center and advanced nanotechnology may reduce healing and fixation times

Carmel, Ind. (September 22, 2015) Nanovis Spine today announced the award of a significant research grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH).

FDA 510(k) clearance of FortiBridge

Nanovis Spine, LLC receives FDA 510(k) clearance of its FortiBridge cervical plating system designed to complement the FortiCore® cervical interbody fusion device platform

Carmel, Ind. (June 18, 2015) Nanovis Spine, LLC (Nanovis) announced today the launch of the company’s FortiBridge® cervical plate system. FortiBridge cervical plates allow for high angulation screw placement with a smooth, esophagus-friendly profile. The FortiBridge cervical plate system offers a full range of short and long sizes in either steam sterilizable or individually sterile packaging formats.

FDA 510(k) clearance for FortiCore

Nanovis Spine, LLC receives FDA 510(k) clearance of its novel FortiCore® cervical and lumbar interbody fusion device platform

Carmel, Ind. (September 22, ) – Nanovis Spine, LLC (Nanovis) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s sterile packed FortiCore® interbody fusion devices. Unlike conventional implants comprising PEEK or sprayed titanium coating, FortiCore® implants have the benefits of a highly porous titanium scaffold engineered for strong, durable integration with a PEEK core.

Nanovis technology for better outcomes
Innovation through collaboration to develop science driven technology platforms

Connect With Us

Recent News

Image